|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - FATE THERAPEUTICS INC (FATE)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-10-15 Sale |
2019-10-16 4:07 pm |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott CEO |
21,017 | $14.44 | $303,458 | 353,969 (Direct) |
View |
| 2019-10-15 Sale |
2019-10-16 4:06 pm |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
6,200 | $14.18 | $87,891 | 66,758 (Direct) |
View |
| 2019-10-15 Sale |
2019-10-16 4:05 pm |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
10,200 | $14.24 | $145,292 | 80,218 (Direct) |
View |
| 2019-10-15 Sale |
2019-10-16 4:04 pm |
FATE THERAPEUTICS INC | FATE | Shoemaker Daniel D Chief Scientific Officer |
11,800 | $14.29 | $168,593 | 123,791 (Direct) |
View |
| 2019-09-16 Purchase |
2019-09-17 4:22 pm |
FATE THERAPEUTICS INC | FATE | Redmile Group LLC Green Jeremy Director, 10% Owner |
857,143 | $17.5 | $15,000,002 | 11,216,809 (Indirect) |
View |
| 2019-07-31 Sale |
2019-08-02 4:32 pm |
FATE THERAPEUTICS INC | FATE | Nashat Amir Director |
62,005 | $22.53 | $1,397,066 | 1,129,554 (Indirect) |
View |
| 2019-07-26 Sale |
2019-07-30 6:25 pm |
FATE THERAPEUTICS INC | FATE | Nashat Amir Director |
118,333 | $22.51 | $2,663,115 | 1,246,926 (Indirect) |
View |
| 2019-07-23 Sale |
2019-07-25 6:24 pm |
FATE THERAPEUTICS INC | FATE | Nashat Amir Director |
81,899 | $22.51 | $1,843,151 | 1,292,946 (Indirect) |
View |
| 2019-07-18 Sale |
2019-07-22 5:52 pm |
FATE THERAPEUTICS INC | FATE | Nashat Amir Director |
71,166 | $22.52 | $1,602,506 | 1,400,808 (Indirect) |
View |
| 2019-06-27 Sale |
2019-06-28 4:02 pm |
FATE THERAPEUTICS INC | FATE | Shoemaker Daniel D Chief Scientific Officer |
12,500 | $20.21 | $252,610 | 148,091 (Direct) |
View |
| 2019-05-16 Sale |
2019-05-17 6:27 pm |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott CEO |
14,335 | $19.37 | $277,684 | 389,216 (Direct) |
View |
| 2019-04-17 Sale |
2019-04-19 4:13 pm |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott CEO |
20,000 | $16.08 | $321,641 | 382,330 (Direct) |
View |
| 2019-03-28 Sale |
2019-03-29 4:01 pm |
FATE THERAPEUTICS INC | FATE | Shoemaker Daniel D Chief Scientific Officer |
12,500 | $16.94 | $211,702 | 148,091 (Direct) |
View |
| 2019-03-21 Sale |
2019-03-22 4:01 pm |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott CEO |
20,000 | $17.61 | $352,160 | 394,881 (Direct) |
View |
| 2019-03-01 Sale |
2019-03-05 09:00 am |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
25,000 | $16.15 | $403,697 | 115,418 (Direct) |
View |
| 2019-02-25 Sale |
2019-02-27 4:01 pm |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
25,000 | $16.07 | $401,820 | 115,418 (Direct) |
View |
| 2019-01-30 Sale |
2019-02-01 5:02 pm |
FATE THERAPEUTICS INC | FATE | Nashat Amir Director |
53,017 | $14.16 | $750,959 | 1,474,979 (Indirect) |
View |
| 2019-01-29 Sale |
2019-01-31 6:00 pm |
FATE THERAPEUTICS INC | FATE | Nashat Amir Director |
97,500 | $14.16 | $1,380,795 | 1,529,622 (Indirect) |
View |
| 2019-01-28 Sale |
2019-01-30 4:10 pm |
FATE THERAPEUTICS INC | FATE | Nashat Amir Director |
70,000 | $13.78 | $964,768 | 1,626,157 (Indirect) |
View |
| 2019-01-25 Sale |
2019-01-29 4:31 pm |
FATE THERAPEUTICS INC | FATE | Nashat Amir Director |
90,000 | $14.14 | $1,272,753 | 1,696,859 (Indirect) |
View |
| 2019-01-18 Sale |
2019-01-23 4:32 pm |
FATE THERAPEUTICS INC | FATE | Nashat Amir Director |
39,483 | $16.28 | $642,834 | 1,785,088 (Indirect) |
View |
| 2019-01-07 Sale |
2019-01-09 4:03 pm |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
25,000 | $16 | $400,000 | 135,000 (Direct) |
View |
| 2018-12-20 Sale |
2018-12-26 4:13 pm |
FATE THERAPEUTICS INC | FATE | Nashat Amir Director |
33,474 | $12.25 | $410,160 | 1,824,360 (Indirect) |
View |
| 2018-12-19 Sale |
2018-12-21 4:12 pm |
FATE THERAPEUTICS INC | FATE | Nashat Amir Director |
91,210 | $13.4 | $1,222,592 | 1,882,881 (Indirect) |
View |
| 2018-12-13 Sale |
2018-12-17 4:25 pm |
FATE THERAPEUTICS INC | FATE | Nashat Amir Director |
17,788 | $16.67 | $296,563 | 1,948,494 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-07-31 Other |
2019-08-02 4:11 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Redmile Group LLC Green Jeremy Director, 10% Owner |
25,000 | $0 | 2,794,549 (Indirect) |
View |
| 2019-07-31 Other |
2019-08-02 4:11 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Redmile Group LLC Green Jeremy Director, 10% Owner |
25,000 | $0 | 2,794,549 (Direct) |
View |
| 2019-07-31 Gift |
2019-08-02 4:11 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Redmile Group LLC Green Jeremy Director, 10% Owner |
25,000 | $0 | 2,794,549 (Direct) |
View |
| 2019-07-15 Option Award |
2019-07-17 4:31 pm |
N/A 2029-07-15 |
FATE THERAPEUTICS INC | FATE | Agarwal Shefali Director |
24,000 | $22.14 | 24,000 (Direct) |
View |
| 2019-06-27 Exercise |
2019-06-28 4:02 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Shoemaker Daniel D Chief Scientific Officer |
12,500 | $2.9 | 148,091 (Direct) |
View |
| 2019-06-27 Exercise |
2019-06-28 4:02 pm |
N/A 2026-01-07 |
FATE THERAPEUTICS INC | FATE | Shoemaker Daniel D Chief Scientific Officer |
12,500 | $2.9 | 148,091 (Direct) |
View |
| 2019-05-24 Gift |
2019-05-28 4:01 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott CEO |
105 | $0 | 374,986 (Direct) |
View |
| 2019-05-16 Exercise |
2019-05-17 6:27 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott CEO |
14,335 | $1.63 | 389,216 (Direct) |
View |
| 2019-05-16 Exercise |
2019-05-17 6:27 pm |
N/A 2022-02-08 |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott CEO |
14,335 | $1.63 | 389,216 (Direct) |
View |
| 2019-05-03 Option Award |
2019-05-07 4:07 pm |
N/A 2029-05-03 |
FATE THERAPEUTICS INC | FATE | RASTETTER WILLIAM H Director |
16,000 | $17.15 | 16,000 (Direct) |
View |
| 2019-05-03 Option Award |
2019-05-07 4:06 pm |
N/A 2029-05-03 |
FATE THERAPEUTICS INC | FATE | Nashat Amir Director |
16,000 | $17.15 | 16,000 (Direct) |
View |
| 2019-05-03 Option Award |
2019-05-07 4:05 pm |
N/A 2029-05-03 |
FATE THERAPEUTICS INC | FATE | MENDLEIN JOHN Director |
16,000 | $17.15 | 16,000 (Direct) |
View |
| 2019-05-03 Option Award |
2019-05-07 4:05 pm |
N/A 2029-05-03 |
FATE THERAPEUTICS INC | FATE | Jooss Karin Director |
16,000 | $17.15 | 16,000 (Direct) |
View |
| 2019-05-03 Option Award |
2019-05-07 4:04 pm |
N/A 2029-05-03 |
FATE THERAPEUTICS INC | FATE | EPSTEIN ROBERT S Director |
16,000 | $17.15 | 16,000 (Direct) |
View |
| 2019-05-03 Option Award |
2019-05-07 4:03 pm |
N/A 2029-05-03 |
FATE THERAPEUTICS INC | FATE | Coughlin Timothy P Director |
16,000 | $17.15 | 16,000 (Direct) |
View |
| 2019-05-03 Option Award |
2019-05-06 4:02 pm |
N/A 2029-05-03 |
FATE THERAPEUTICS INC | FATE | Lee Michael Stewart Director |
16,000 | $17.15 | 16,000 (Direct) |
View |
| 2019-05-03 Option Award |
2019-05-06 4:01 pm |
N/A 2029-05-03 |
FATE THERAPEUTICS INC | FATE | Redmile Group LLC Green Jeremy Director, 10% Owner |
16,000 | $17.15 | 16,000 (Indirect) |
View |
| 2019-04-17 Exercise |
2019-04-19 4:13 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott CEO |
1,092 | $1.63 | 382,330 (Direct) |
View |
| 2019-04-17 Exercise |
2019-04-19 4:13 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott CEO |
7,449 | $1.63 | 382,330 (Direct) |
View |
| 2019-04-17 Exercise |
2019-04-19 4:13 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott CEO |
6,843 | $1.63 | 382,330 (Direct) |
View |
| 2019-04-17 Exercise |
2019-04-19 4:13 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott CEO |
4,616 | $1.63 | 382,330 (Direct) |
View |
| 2019-04-17 Exercise |
2019-04-19 4:13 pm |
N/A 2022-02-08 |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott CEO |
1,092 | $1.63 | 382,330 (Direct) |
View |
| 2019-04-17 Exercise |
2019-04-19 4:13 pm |
N/A 2022-02-08 |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott CEO |
7,449 | $1.63 | 382,330 (Direct) |
View |
| 2019-04-17 Exercise |
2019-04-19 4:13 pm |
N/A 2022-02-08 |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott CEO |
6,843 | $1.63 | 382,330 (Direct) |
View |
| 2019-04-17 Exercise |
2019-04-19 4:13 pm |
N/A 2022-02-08 |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott CEO |
4,616 | $1.63 | 382,330 (Direct) |
View |
| 2019-03-28 Exercise |
2019-03-29 4:01 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Shoemaker Daniel D Chief Scientific Officer |
12,500 | $2.9 | 148,091 (Direct) |
View |
| 2019-03-28 Exercise |
2019-03-29 4:01 pm |
N/A 2026-01-07 |
FATE THERAPEUTICS INC | FATE | Shoemaker Daniel D Chief Scientific Officer |
12,500 | $2.9 | 148,091 (Direct) |
View |
| 2019-03-21 Exercise |
2019-03-22 4:01 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott CEO |
20,000 | $1.63 | 394,881 (Direct) |
View |
| 2019-03-21 Exercise |
2019-03-22 4:01 pm |
N/A 2022-02-08 |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott CEO |
20,000 | $1.63 | 394,881 (Direct) |
View |
| 2019-03-14 Option Award |
2019-03-18 4:07 pm |
N/A 2029-03-14 |
FATE THERAPEUTICS INC | FATE | Jooss Karin Director |
24,000 | $18.21 | 24,000 (Direct) |
View |
| 2019-03-01 Exercise |
2019-03-05 09:00 am |
N/A N/A |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
25,000 | $2.9 | 115,418 (Direct) |
View |
| 2019-03-01 Exercise |
2019-03-05 09:00 am |
N/A 2026-01-07 |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
25,000 | $2.9 | 115,418 (Direct) |
View |
| 2019-02-25 Exercise |
2019-02-27 4:01 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
25,000 | $2.9 | 115,418 (Direct) |
View |
| 2019-02-25 Exercise |
2019-02-27 4:01 pm |
N/A 2026-01-07 |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
25,000 | $2.9 | 115,418 (Direct) |
View |
| 2019-01-07 Option Award |
2019-01-09 4:05 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott CEO |
250,000 | $0 | 500,000 (Direct) |
View |
| 2019-01-07 Option Award |
2019-01-09 4:05 pm |
N/A 2029-01-06 |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott CEO |
500,000 | $16.55 | 500,000 (Direct) |
View |
| 2019-01-07 Option Award |
2019-01-09 4:04 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
45,000 | $0 | 135,000 (Direct) |
View |
| 2019-01-07 Option Award |
2019-01-09 4:04 pm |
N/A 2029-01-06 |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
135,000 | $16.55 | 135,000 (Direct) |
View |
| 2019-01-07 Exercise |
2019-01-09 4:03 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
2,008 | $1.37 | 135,000 (Direct) |
View |
| 2019-01-07 Exercise |
2019-01-09 4:03 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
2,080 | $1.69 | 135,000 (Direct) |
View |
| 2019-01-07 Exercise |
2019-01-09 4:03 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
8,461 | $1.69 | 135,000 (Direct) |
View |
| 2019-01-07 Exercise |
2019-01-09 4:03 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
12,451 | $2.9 | 135,000 (Direct) |
View |
| 2019-01-07 Option Award |
2019-01-09 4:03 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
45,000 | $0 | 135,000 (Direct) |
View |
| 2019-01-07 Exercise |
2019-01-09 4:03 pm |
N/A 2023-01-14 |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
2,008 | $1.37 | 135,000 (Direct) |
View |
| 2019-01-07 Exercise |
2019-01-09 4:03 pm |
N/A 2020-02-10 |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
2,080 | $1.69 | 135,000 (Direct) |
View |
| 2019-01-07 Exercise |
2019-01-09 4:03 pm |
N/A 2021-03-11 |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
8,461 | $1.69 | 135,000 (Direct) |
View |
| 2019-01-07 Exercise |
2019-01-09 4:03 pm |
N/A 2026-01-07 |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
12,451 | $2.9 | 135,000 (Direct) |
View |
| 2019-01-07 Option Award |
2019-01-09 4:03 pm |
N/A 2029-01-06 |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
135,000 | $16.55 | 135,000 (Direct) |
View |
| 2019-01-07 Option Award |
2019-01-09 4:01 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Shoemaker Daniel D Chief Scientific Officer |
45,000 | $0 | 135,591 (Direct) |
View |
| 2019-01-07 Option Award |
2019-01-09 4:01 pm |
N/A 2029-01-06 |
FATE THERAPEUTICS INC | FATE | Shoemaker Daniel D Chief Scientific Officer |
135,000 | $16.55 | 135,591 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Fri, 18 Oct 2019 11:40:21 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |